Carrie Eglinton Manner's Insider Trades & SAST Disclosures
Carrie Eglinton Manner's most recent trade in Orasure Technologies Inc. was a trade of 462,414 Common Stock done . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carrie Eglinton Manner.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 462,414 | 1,750,748 (2%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 01 Mar 2025 | 62,382 | 1,688,366 (2%) | 0% | 3.6 | 226,291 | Common Stock |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 28 Feb 2025 | 28,670 | 1,288,334 (2%) | 0% | 3.5 | 100,027 | Common Stock |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 27 Feb 2025 | 78,625 | 1,259,664 (2%) | 0% | 3.1 | 247,378 | Common Stock |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.65 per share. | 04 Jun 2024 | 401,618 | 1,181,039 (1%) | 0% | 4.7 | 1,867,524 | Common Stock |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 1,376 | 1,376 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 701 | 3,493 (0%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 260,688 | 1,612,304 (2%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share. | 01 Mar 2024 | 29,647 | 1,582,657 (2%) | 0% | 7.2 | 213,236 | Common Stock |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.48 per share. | 04 Jun 2023 | 47,211 | 1,351,616 (2%) | 0% | 5.5 | 258,716 | Common Stock |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 1,487 | 1,487 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 686 | 2,167 (0%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 258,065 | 1,398,827 (2%) | 0% | 0 | Common Stock | |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 4.91 per share. | 04 Jun 2022 | 814,830 | 814,830 (1%) | 1% | 4.9 | 4,000,000 | Common Stock |
| Orasure Technologies Inc. | Carrie Eglinton Manner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 4.91 per share. | 04 Jun 2022 | 325,932 | 1,140,762 (1%) | 0% | 4.9 | 1,600,000 | Common Stock |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 2,488 | 2,488 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 1,024 | 1,481 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Carrie Eglinton Manner | Director | Purchase of securities on an exchange or from another person at price $ 175.02 per share. | 16 Mar 2022 | 625 | 2,106 (0%) | 0% | 175.0 | 109,388 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Grant, award, or other acquisition of securities at price $ 130.09 per share. | 07 Mar 2022 | 16,162 | 56,338 (0%) | 0% | 130.1 | 2,102,515 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 07 Mar 2022 | 7,947 | 48,391 (0%) | 0% | 130.1 | 1,033,825 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 19,009 | 19,009 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 7,830 | 40,176 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 3,915 | 32,346 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.09 per share. | 23 Feb 2022 | 1,368 | 28,882 (0%) | 0% | 130.1 | 177,963 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.23 per share. | 23 Feb 2022 | 609 | 28,431 (0%) | 0% | 130.2 | 79,310 | Common Stock |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 1,151 | 1,151 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 457 | 457 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Grant, award, or other acquisition of securities at price $ 115.42 per share. | 09 Mar 2021 | 13,181 | 36,394 (0%) | 0% | 115.4 | 1,521,351 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.42 per share. | 09 Mar 2021 | 6,165 | 30,250 (0%) | 0% | 115.4 | 711,564 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.15 per share. | 23 Feb 2021 | 1,017 | 23,824 (0%) | 0% | 121.2 | 123,210 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.19 per share. | 23 Feb 2021 | 611 | 23,213 (0%) | 0% | 121.2 | 74,047 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 27,633 | 27,633 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 4,926 | 24,841 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.00 per share. | 04 Jan 2021 | 2,640 | 19,896 (0%) | 0% | 119 | 314,160 | Common Stock |
| Repligen Corp. | Carrie Eglinton Manner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 2,794 | 2,794 | - | - | Stock Option (Right to Buy) | |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Sale of securities on an exchange or to another person at price $ 112.03 per share. | 27 Apr 2020 | 2,500 | 24,890 (0%) | 0% | 112.0 | 280,075 | Common Stock |
| Quest Diagnostics, Inc. | Carrie Eglinton Manner | SVP, Advanced Diagnostics | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 27 Apr 2020 | 2,500 | 22,390 (0%) | 0% | 110 | 275,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges